University of Pennsylvania study finds no link between semaglutide and depressive risks in patients without major mental health issues.

A University of Pennsylvania study found no link between semaglutide, a weight loss medication, and increased risks of depression or suicidal thoughts in patients without major mental health issues. Analyzing data from over 3,500 participants in four clinical trials, the research reassures users about the drug's psychiatric safety. However, further study is needed for individuals with existing mental health conditions, as they were not included in this research.

September 03, 2024
46 Articles